Concepedia

Dennis Lindenblatt

DL

Statistics

Publications

3

Citations

113

H-Index

3

Active since

2014

Affiliations

ETH Zurich(Current)

Paul Scherrer Institute

Dennis Lindenblatt is an author at ETH Zurich specializing in cancer immunotherapy, ovarian cancer pharmacotherapy, and oncology.

Publications per year

2014–2018

3

Publications

3

Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model

Jürgen Grünberg, Dennis Lindenblatt, Holger Dorrer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 80 citations · Full text

, , +12

Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model

Dennis Lindenblatt, Eliane Fischer, Susan Cohrs et al. · EJNMMI Research · 2014 · 19 citations · Full text

, , +17

Combination of lutetium-177 labelled anti-L1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: a novel combination against human ovarian carcinoma

Dennis Lindenblatt, Nastassja Terraneo, Giovanni Pellegrini et al. · BMC Cancer · 2018 · 14 citations · Full text

, , +17

1–3 of 3